Robert E. Landry
2014
In 2014, Robert E. Landry earned a total compensation of $7.4M as Senior Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals, a 42% decrease compared to previous year.
Compensation breakdown
| Bonus | $455,000 |
|---|---|
| Option Awards | $6,403,138 |
| Salary | $500,000 |
| Other | $14,818 |
| Total | $7,372,956 |
Landry received $6.4M in option awards, accounting for 87% of the total pay in 2014.
Landry also received $455K in bonus, $500K in salary and $14.8K in other compensation.
Rankings
In 2014, Robert E. Landry's compensation ranked 884th out of 13,032 executives tracked by ExecPay. In other words, Landry earned more than 93.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 884 out of 13,032 | 93rd |
Division Manufacturing | 313 out of 4,966 | 94th |
Major group Chemicals And Allied Products | 103 out of 1,686 | 94th |
Industry group Drugs | 80 out of 1,365 | 94th |
Industry Pharmaceutical Preparations | 73 out of 1,043 | 93rd |
Source: SEC filing on April 26, 2016.
Landry's colleagues
We found four more compensation records of executives who worked with Robert E. Landry at Regeneron Pharmaceuticals in 2014.
2014
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2014
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2014
Neil Stahl
Regeneron Pharmaceuticals
Executive Vice President, Research & Development
2014
Robert Terifay
Regeneron Pharmaceuticals
Executive Vice President, Commercial
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019